bioRxivMolecular BiologyPreprint
Proteome-scale induced proximity screens reveal highly potent protein degraders and stabilizers
Juline PoirsoniD, Akashdeep Dhillon, Hanna ChoiD, Mandy Hiu Yi LamiD, Nader AlerasooliD, Jessica LacosteiD, Lamisa Mizan, Mikko TaipaleiD
Abstract
Targeted protein degradation and stabilization are promising therapeutic modalities due to their potency and versatility. However, only few E3 ligases and deubiquitinases have been harnessed for this purpose. Moreover, there may be other protein classes that could be exploited for protein stabilization or degradation. Here, we used a proteome-scale platform to identify hundreds of human proteins that can promote the degradation or stabilization of a target protein in a proximity-dependent manner. This allowed us to comprehensively compare the activities of human E3s and deubiquitinases, characterize non-canonical protein degraders and stabilizers, and establish that effectors have vastly different activities against diverse targets. Notably, the top degraders were more potent against multiple therapeutically relevant targets than the currently used E3s CBRN and VHL. Our study provides a functional catalogue of effectors for targeted protein degradation and stabilization and highlights the potential of induced proximity screens for discovery of novel proximity-dependent protein modulators.
- organism: human
- assay: proteomics
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 24
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- E3-specific degrader discovery by dynamic tracing of substrate receptor abundance
Alexander Hanzl, Eleonora Barone, … Georg E. Winter·Journal of the American Chemical SocietyPeer-reviewed·Jan 5, 2023
- Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
Y. V. Serebrenik, D. Mani, … O. Shalem·bioRxiv·Jul 13, 2023
- A tale of two tails - efficient profiling of protein degraders by specific functional and target engagement readouts
Alexey L. Chernobrovkin, Cindy Cázares-Körner, … Daniel Martinez Molina·SLAS DISCOVERYPeer-reviewed·Jan 15, 2021
- Engineering ERα degraders with pleiotropic ubiquitin ligase ligands maximizes therapeutic efficacy by co-opting distinct effector ligases
Anna Shemorry, Willem den Besten, … Ingrid E. Wertz·Cell chemical biologyPeer-reviewed·May 1, 2025
- Targeted Protein Degradation through E2 Recruitment
N. Forte, D. Dovala, … D. K. Nomura·bioRxiv·Dec 19, 2022
- Targeted protein degradation via intramolecular bivalent glues
O. Hsia, M. Hinterndorfer, … A. Ciulli·bioRxiv·Feb 14, 2023